Search - tctmd.com

Displaying 61 - 80 of 225

Sort: Relevancy | Date

Presentation TCT 2017

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

Presenter: Ron Waksman, Robert-Jan van Geuns, Sujith K Seneviratne

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based FIRESORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based MeRes100

Presenter: Ron Waksman, Robert-Jan van Geuns, Ashok Seth

October 31, 2017

Presentation TCT 2017

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

Presenter: Bernard R. Chevalier, Corrado Tamburino, Ron Waksman

October 31, 2017

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

Presentation TCT 2017

Impact of Race and Sex on Platelet Reactivity and Clinical Implications

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Ron Waksman

October 30, 2017

Presentation TCT 2017

Bioresorbable Scaffolds Are Here to Stay!

Presenter: Antonio Colombo, Stephen G. Ellis, Ron Waksman

October 29, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Conference News CRT 2017

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Michael O'Riordan

February 23, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

Presentation JIM 2017

Magmaris a Magnesium Based Bioreorbable Scaffold

Presenter: Ron Waksman

February 08, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Presentation ISET 2017

TAVR: What are the Limits Today and Where are We Going in the Future?

Presenter: Ron Waksman

February 05, 2017

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Advertisement

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

The Thin-Strut PLLA-Based FIRESORB

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

The Thin-Strut PLLA-Based MeRes100

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Impact of Race and Sex on Platelet Reactivity and Clinical Implications

Bioresorbable Scaffolds Are Here to Stay!

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Magmaris a Magnesium Based Bioreorbable Scaffold

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

TAVR: What are the Limits Today and Where are We Going in the Future?

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content